These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 653788)

  • 1. Cutaneous leishmaniasis and leprosy.
    Barnetson RS; Bryceson AD
    Trans R Soc Trop Med Hyg; 1978; 72(2):160-3. PubMed ID: 653788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum tumor necrosis factor levels and disease dissemination in leprosy and leishmaniasis.
    Pisa P; Gennene M; Söder O; Ottenhoff T; Hansson M; Kiessling R
    J Infect Dis; 1990 May; 161(5):988-91. PubMed ID: 2324549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential interferon- gamma production characterizes the cytokine responses to Leishmania and Mycobacterium leprae antigens in concomitant mucocutaneous leishmaniasis and lepromatous leprosy.
    Matos DS; Azeredo-Coutinho RB; Schubach A; Conceição-Silva F; Baptista C; Moreira JS; Mendonça SC
    Clin Infect Dis; 2005 Jan; 40(2):e5-12. PubMed ID: 15655736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous and mucocutaneous leishmaniasis resembling borderline-tuberculoid leprosy: a new clinical presentation?
    Dassoni F; Abebe Z; Naafs B; Morrone A
    Acta Derm Venereol; 2013 Jan; 93(1):74-7. PubMed ID: 22434112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo responses to Mycobacterium leprae: antigen presentation, interleukin-2 production, and immune cell phenotypes in naturally occurring leprosy lesions.
    Longley J; Haregewoin A; Yemaneberhan T; Warndorff van Diepen T; Nsibami J; Knowles D; Smith KA; Godal T
    Int J Lepr Other Mycobact Dis; 1985 Sep; 53(3):385-94. PubMed ID: 3900245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subclinical infection in leprosy.
    Godal T; Negassi K
    Br Med J; 1973 Sep; 3(5880):557-9. PubMed ID: 4580217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the leprosy agents Mycobacterium leprae and Mycobacterium lepromatosis in four countries.
    Han XY; Aung FM; Choon SE; Werner B
    Am J Clin Pathol; 2014 Oct; 142(4):524-32. PubMed ID: 25239420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ["PSEUDOLEPROMATOUS" CUTANEOUS LEISHMANIASIS].
    SCHALLER KF; SERIE C
    Z Haut Geschlechtskr; 1963 Dec; 35():310-4. PubMed ID: 14115435
    [No Abstract]   [Full Text] [Related]  

  • 9. Leprosy and AIDS: a review of the literature and speculations on the impact of CD4+ lymphocyte depletion on immunity to Mycobacterium leprae.
    Miller RA
    Int J Lepr Other Mycobact Dis; 1991 Dec; 59(4):639-44. PubMed ID: 1687045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermography of the nose and ear in relation to the skin lesions of lepromatous leprosy, tuberculosis, leishmaniasis, and lupus pernio.
    McDougall AC; Salter DC
    J Invest Dermatol; 1977 Jan; 68(1):16-22. PubMed ID: 830767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leprosy Associated with Atypical Cutaneous Leishmaniasis in Nicaragua and Honduras.
    Soto LA; Caballero N; Fuentes LR; Muñoz PT; Gómez Echevarría JR; López MP; Bornay Llinares FJ; Stanford JL; Stanford CA; Donoghue HD
    Am J Trop Med Hyg; 2017 Oct; 97(4):1103-1110. PubMed ID: 29031287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activation of neutrophils by suspensions of Mycobacterium leprae.
    Goihman-Yahr M; Rodriguez-Ochoa G; Aranzazu N; Pinardi ME; de Gomez ME; Ocanto A; Convit J
    Int J Lepr Other Mycobact Dis; 1979 Dec; 47(4):570-4. PubMed ID: 122626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffuse cutaneous leishmaniasis in coexistence with leprosy.
    Patrao NA; Bhat RM; Dandekeri S; Kambil SM
    Int J Dermatol; 2015 Dec; 54(12):1402-6. PubMed ID: 26266674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to a synthetic analog of phenolic glycolipid-I of Mycobacterium leprae in healthy household contacts of patients with leprosy.
    Menzel S; Harboe M; Bergsvik H; Brennan PJ
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):617-25. PubMed ID: 3323365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An analysis of in vitro T cell responsiveness in lepromatous leprosy.
    Kaplan G; Weinstein DE; Steinman RM; Levis WR; Elvers U; Patarroyo ME; Cohn ZA
    J Exp Med; 1985 Sep; 162(3):917-29. PubMed ID: 3928804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components.
    Ottenhoff TH; Converse PJ; Gebre N; Wondimu A; Ehrenberg JP; Kiessling R
    Eur J Immunol; 1989 Apr; 19(4):707-13. PubMed ID: 2659369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. American cutaneous leishmaniasis, lepromatous leprosy, and pulmonary tuberculosis coinfection with downregulation of the T-helper 1 cell response.
    Delobel P; Launois P; Djossou F; Sainte-Marie D; Pradinaud R
    Clin Infect Dis; 2003 Sep; 37(5):628-33. PubMed ID: 12942392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immunobiology of leprosy.
    Kaplan G; Cohn ZA
    Int Rev Exp Pathol; 1986; 28():45-78. PubMed ID: 3516911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preservation of sensation in a cutaneous vascular malformation in lepromatous leprosy.
    Sabin TD
    N Engl J Med; 1970 May; 282(19):1084-5. PubMed ID: 4908886
    [No Abstract]   [Full Text] [Related]  

  • 20. Leprous neuropathy.
    de Freitas MR; Said G
    Handb Clin Neurol; 2013; 115():499-514. PubMed ID: 23931798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.